Product Code: ETC13162843 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Minor Cannabinoids Market was valued at USD 2 Billion in 2024 and is expected to reach USD 5 Billion by 2031, growing at a compound annual growth rate of 5.50% during the forecast period (2025-2031).
The Global Minor Cannabinoids Market is experiencing significant growth driven by increasing research and development activities focused on exploring the therapeutic potential of lesser-known cannabinoids such as CBG, CBN, and THCV. These minor cannabinoids are gaining attention for their potential health benefits, including anti-inflammatory, pain relief, and neuroprotective properties. The market is witnessing a surge in product innovation, with companies launching a range of minor cannabinoid-infused products such as tinctures, edibles, and topicals. Additionally, regulatory changes favoring the legalization of cannabis in various regions are expected to further boost market growth. Key players in the global minor cannabinoids market include Charlotte`s Web Holdings, Inc., Cannabics Pharmaceuticals Inc., and Radient Technologies Inc., among others. As consumer awareness about the therapeutic benefits of minor cannabinoids increases, the market is projected to expand rapidly in the coming years.
The Global Minor Cannabinoids Market is experiencing significant growth due to increasing interest in the potential therapeutic benefits of lesser-known cannabinoids like CBG, CBN, and THCV. These compounds are being researched for their potential anti-inflammatory, analgesic, and neuroprotective properties, driving demand in the pharmaceutical and wellness industries. With more countries legalizing cannabis for medical and recreational use, opportunities are arising for companies to develop innovative products utilizing minor cannabinoids. The market is also witnessing a surge in collaborations between researchers, manufacturers, and distributors to explore new applications and extraction methods for minor cannabinoids, indicating a growing focus on expanding product offerings and market reach. As consumer awareness of the diverse benefits of minor cannabinoids grows, the market is poised for further expansion and product diversification.
One of the key challenges faced in the Global Minor Cannabinoids Market is the lack of comprehensive regulations and standardization across different regions. As minor cannabinoids gain popularity for their potential health benefits, varying regulations across countries create barriers for companies looking to enter and expand in this market. This lack of regulatory clarity not only hinders the development of consistent product quality and safety standards but also leads to uncertainties in terms of legal compliance and market access. Additionally, the limited research and clinical data available on minor cannabinoids compared to the well-studied major cannabinoid, CBD, pose challenges in educating consumers and healthcare professionals, thus impacting market adoption and consumer trust. Overcoming these regulatory and educational hurdles will be vital for the sustained growth of the Global Minor Cannabinoids Market.
The Global Minor Cannabinoids Market is primarily being driven by the increasing awareness about the potential health benefits of minor cannabinoids such as CBG, CBN, and THCV. These compounds are gaining attention for their therapeutic properties in addressing various health conditions such as chronic pain, inflammation, anxiety, and sleep disorders. Additionally, the growing legalization of cannabis for medical and recreational purposes in several countries is expanding the market opportunities for minor cannabinoids. The rising demand for alternative and natural remedies, coupled with ongoing research and development activities to explore the therapeutic potential of minor cannabinoids, are further fueling the market growth. Moreover, the expanding product offerings in the form of oils, tinctures, capsules, and topical solutions infused with minor cannabinoids are attracting a wider consumer base, driving market expansion.
Government policies related to the Global Minor Cannabinoids Market vary significantly across countries. In some regions, such as the United States, there is ongoing debate and evolution of regulations surrounding minor cannabinoids like CBG, CBN, and others. The regulatory landscape is complex, with factors such as legality, cultivation requirements, labeling, and marketing restrictions playing a role. Some countries have strict regulations on minor cannabinoids due to their association with cannabis, while others are more open to exploring their potential benefits. Overall, the industry is heavily influenced by government policies that can impact market growth, consumer access, and research opportunities in the Global Minor Cannabinoids Market.
The Global Minor Cannabinoids Market is projected to experience significant growth in the coming years due to increasing recognition of the therapeutic benefits of minor cannabinoids such as CBG, CBN, and THCV. As more research is conducted, these lesser-known cannabinoids are being discovered to have unique properties that can address various health conditions, driving demand in the pharmaceutical, wellness, and nutraceutical industries. Additionally, the legalization of cannabis in various regions is expected to further boost market growth as consumers become more educated about the potential benefits of minor cannabinoids. With a growing interest in natural remedies and alternative medicine, the Global Minor Cannabinoids Market is poised for expansion, presenting opportunities for companies to innovate and develop new products to meet the evolving needs of consumers.
In the Global Minor Cannabinoids Market, Asia is expected to show significant growth due to increasing awareness about the potential health benefits of minor cannabinoids. North America is likely to dominate the market, driven by the expanding legalization of cannabis products and a growing consumer base. Europe is also poised for substantial growth with the increasing adoption of medical cannabis and relaxation of regulations. The Middle East and Africa region is expected to witness steady growth, influenced by evolving regulatory landscapes and rising interest in alternative medicine. Latin America is projected to experience rapid growth due to favorable government policies and increasing investments in the cannabis industry, creating a conducive environment for the development of minor cannabinoids products.
Global Minor Cannabinoids Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Minor Cannabinoids Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Minor Cannabinoids Market Revenues & Volume, 2021 & 2031F |
3.3 Global Minor Cannabinoids Market - Industry Life Cycle |
3.4 Global Minor Cannabinoids Market - Porter's Five Forces |
3.5 Global Minor Cannabinoids Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Minor Cannabinoids Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.7 Global Minor Cannabinoids Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Global Minor Cannabinoids Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Minor Cannabinoids Market Trends |
6 Global Minor Cannabinoids Market, 2021 - 2031 |
6.1 Global Minor Cannabinoids Market, Revenues & Volume, By Product, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Minor Cannabinoids Market, Revenues & Volume, By Cannabigerol, 2021 - 2031 |
6.1.3 Global Minor Cannabinoids Market, Revenues & Volume, By Cannabichromene, 2021 - 2031 |
6.1.4 Global Minor Cannabinoids Market, Revenues & Volume, By Cannabinol, 2021 - 2031 |
6.1.5 Global Minor Cannabinoids Market, Revenues & Volume, By Tetrahydrocannabivarin, 2021 - 2031 |
6.2 Global Minor Cannabinoids Market, Revenues & Volume, By Application, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Minor Cannabinoids Market, Revenues & Volume, By Inflammation, 2021 - 2031 |
6.2.3 Global Minor Cannabinoids Market, Revenues & Volume, By Pain Management, 2021 - 2031 |
6.2.4 Global Minor Cannabinoids Market, Revenues & Volume, By Neurological Disorders, 2021 - 2031 |
6.2.5 Global Minor Cannabinoids Market, Revenues & Volume, By Cancer, 2021 - 2031 |
6.2.6 Global Minor Cannabinoids Market, Revenues & Volume, By Others, 2021 - 2031 |
6.3.1 Overview & Analysis |
7 North America Minor Cannabinoids Market, Overview & Analysis |
7.1 North America Minor Cannabinoids Market Revenues & Volume, 2021 - 2031 |
7.2 North America Minor Cannabinoids Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Minor Cannabinoids Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Minor Cannabinoids Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Minor Cannabinoids Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Minor Cannabinoids Market, Revenues & Volume, By Product, 2021 - 2031 |
7.4 North America Minor Cannabinoids Market, Revenues & Volume, By Application, 2021 - 2031 |
8 Latin America (LATAM) Minor Cannabinoids Market, Overview & Analysis |
8.1 Latin America (LATAM) Minor Cannabinoids Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Minor Cannabinoids Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Minor Cannabinoids Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Minor Cannabinoids Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Minor Cannabinoids Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Minor Cannabinoids Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Minor Cannabinoids Market, Revenues & Volume, By Product, 2021 - 2031 |
8.4 Latin America (LATAM) Minor Cannabinoids Market, Revenues & Volume, By Application, 2021 - 2031 |
9 Asia Minor Cannabinoids Market, Overview & Analysis |
9.1 Asia Minor Cannabinoids Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Minor Cannabinoids Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Minor Cannabinoids Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Minor Cannabinoids Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Minor Cannabinoids Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Minor Cannabinoids Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Minor Cannabinoids Market, Revenues & Volume, By Product, 2021 - 2031 |
9.4 Asia Minor Cannabinoids Market, Revenues & Volume, By Application, 2021 - 2031 |
10 Africa Minor Cannabinoids Market, Overview & Analysis |
10.1 Africa Minor Cannabinoids Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Minor Cannabinoids Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Minor Cannabinoids Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Minor Cannabinoids Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Minor Cannabinoids Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Minor Cannabinoids Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Minor Cannabinoids Market, Revenues & Volume, By Product, 2021 - 2031 |
10.4 Africa Minor Cannabinoids Market, Revenues & Volume, By Application, 2021 - 2031 |
11 Europe Minor Cannabinoids Market, Overview & Analysis |
11.1 Europe Minor Cannabinoids Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Minor Cannabinoids Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Minor Cannabinoids Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Minor Cannabinoids Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Minor Cannabinoids Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Minor Cannabinoids Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Minor Cannabinoids Market, Revenues & Volume, By Product, 2021 - 2031 |
11.4 Europe Minor Cannabinoids Market, Revenues & Volume, By Application, 2021 - 2031 |
12 Middle East Minor Cannabinoids Market, Overview & Analysis |
12.1 Middle East Minor Cannabinoids Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Minor Cannabinoids Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Minor Cannabinoids Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Minor Cannabinoids Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Minor Cannabinoids Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Minor Cannabinoids Market, Revenues & Volume, By Product, 2021 - 2031 |
12.4 Middle East Minor Cannabinoids Market, Revenues & Volume, By Application, 2021 - 2031 |
13 Global Minor Cannabinoids Market Key Performance Indicators |
14 Global Minor Cannabinoids Market - Export/Import By Countries Assessment |
15 Global Minor Cannabinoids Market - Opportunity Assessment |
15.1 Global Minor Cannabinoids Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Minor Cannabinoids Market Opportunity Assessment, By Product, 2021 & 2031F |
15.3 Global Minor Cannabinoids Market Opportunity Assessment, By Application, 2021 & 2031F |
16 Global Minor Cannabinoids Market - Competitive Landscape |
16.1 Global Minor Cannabinoids Market Revenue Share, By Companies, 2024 |
16.2 Global Minor Cannabinoids Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |